PORPHYRIN-IMMOBILIZED IN HIBRID NANOPARTICLES FOR PHOTODYNAMIC THERAPY AGAINST BLADDER CANCER CELLS

Vol. 1, 2019. - 116448
Pôster
Favorite this paper
How to cite this paper?
Abstract

Photodynamic therapy (PDT) is described as an effective alternative approach for treat bladder cancer (BC).
Hybrid nanoparticles porphyrin-based (P-HNP) were developed to increase porphyrin efficiency in biological
media as photosensitizer against BC cells. P-HNP were characterized regarding to size, zeta potential,
morphology, stability, photophysical and thermal properties. Spherical nanocarriers was stable for 1 year at 25
ºC, showed positive zeta potential (+25 mV) and size smaller than 120 nm (PdI < 0.22). P-HNP are fluorescent
and cytotoxic for T24 and RT4 BC cells lines with light irradiation (405 nm; 10 J/cm2). P-HNP showed 5-fold
high phototoxic activity (IC50 = 61 nM) than free porphyrin due to high cellular uptake of nanostructures as
observed by confocal microscopy. Moreover, P-HNP was toxic in high concentrations (ca 150 nM) in zebra
fish model, whereas porphyrin did not toxic. Briefly, P-HNP is attractive to applied in other bladder cancer
models owing to its phototoxicity.

Institutions
  • 1 Faculdade de Ciências Farmacêuticas de Ribeirão Preto (FCFRP), Universidade de São Paulo (USP)
  • 2 Universidade Federal de São Carlos
  • 3 Departamento de Genética e Evolução - UFSCAR
  • 4 Faculdade de Ciências Farmacêuticas de Ribeirão Preto / Universidade de São Paulo
Track
  • Nanotechnology
Keywords
Photodynamic Therapy
hybrid nanoparticles
Bladder Cancer